RS

Ravi Shanker Chaube

Active Director Director DIN 07730070
DIN 07730070 First appointment Feb 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value •••• Premium profile

About Ravi Shanker Chaube

Data last updated:

Ravi Shanker Chaube is a Director at R.Shank Pharma Private Limited (since 2017). The company operates in Trading. R.Shank Pharma Private Limited reported revenue of ₹74.5 Lakh (FY 2025).

DIN 07730070
Primary Designation Director
Industry Trading
First Appointment 15 Feb 2017
Oldest Company Age 30 yrs
Largest company R.Shank Pharma Private Limited · ₹74.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
R.Shank Pharma Private Limited U24931UP1996PTC019997
Director15 Feb 20171996₹74.5 Lakh (FY 2025)Active

Board colleagues of Ravi Shanker Chaube

Directorship timeline

Open interactive timeline →
R.Shank Pharma Private Limited
Premium access

Shareholding and investment profile for Ravi Shanker Chaube

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Shanker Chaube

Ravi Shanker Chaube currently holds 1 directorship: R.Shank Pharma Private Limited (Director, since 15 Feb 2017, revenue ₹74.5 Lakh (FY 2025)).

Ravi Shanker Chaube was first appointed on 15 Feb 2017 as Director at R.Shank Pharma Private Limited.

The current boards of Ravi Shanker Chaube's companies include Ghulam Sarwar (R.Shank Pharma Private Limited), Vibha Chaubey (R.Shank Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available